11:02 am ZIOPHARM presents preclinical data at AACR Annual Meeting supporting controlled DNA-based IL-12 therapy for brain cancer; data demonstrated that administration of Ad-RTS-mIL-12 + veledimex resulted in dose-related increases in surv

11:02 am ZIOPHARM presents preclinical data at AACR Annual Meeting supporting controlled DNA-based IL-12 therapy for brain cancer; data demonstrated that administration of Ad-RTS-mIL-12 + veledimex resulted in dose-related increases in surv

more

View todays social media effects on ZIOP

View the latest stocks trending across Twitter. Click to view dashboard

See who ZIOPHARM is hiring next, click here to view

Share this post